| ID | 1553 |
|---|
| No | 1553 |
|---|
| Brand Name | TREVIAMET TABLETS 50 MG+1000 MG |
|---|
| Ingredients | METFORMIN HCL 1000 MG, SITAGLIPTIN PHOSPHATE 61.520 MG EQ.TO SITAGLIPTIN 50 MG
|
|---|
| Dosage Form | FILM-COATED TABLETS |
|---|
| Primary Packaging | BLISTERPACK |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 2 X 7'S AND 5 X 7'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TREVIAMET IS INDICATED : INITIAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TO IMPROVE GLYCEMIC CONTROL WHEN DIET AND EXCERCISE DO NOT PROVIDE ADEQUATE GLYCEMIC CONTROL |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | PINK COLORED, OBLONG SHAPED FILM - COATED TABLET, HAVING BISECT LINE ON ONE SIDE AND PLAIN ON THE OTHER SIDE. |
|---|
| Note | |
|---|
| License Owner | LAO INTER PHARMA CO.,LTD |
|---|
| Manufacturer | GETZ PHARMA (PRIVATE) LIMITED |
|---|
| Country | PAKISTAN |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 11 I 4117/15 |
|---|
| FDD Registration Date | 10/02/2023 |
|---|
| Expiry Date | 09/02/2026 |
|---|
